Cargando…

Long-term sequelae of treatment for testicular germ cell tumours.

Seventy-four patients previously treated in our department for germ cell tumour of the testis underwent a series of tests to determine the frequency of long-term therapeutic complications. All had received cisplatin-based chemotherapy as part of their treatment. There was a significant deterioration...

Descripción completa

Detalles Bibliográficos
Autores principales: Bissett, D., Kunkeler, L., Zwanenburg, L., Paul, J., Gray, C., Swan, I. R., Kerr, D. J., Kaye, S. B.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971502/
https://www.ncbi.nlm.nih.gov/pubmed/2171622
_version_ 1782134924043616256
author Bissett, D.
Kunkeler, L.
Zwanenburg, L.
Paul, J.
Gray, C.
Swan, I. R.
Kerr, D. J.
Kaye, S. B.
author_facet Bissett, D.
Kunkeler, L.
Zwanenburg, L.
Paul, J.
Gray, C.
Swan, I. R.
Kerr, D. J.
Kaye, S. B.
author_sort Bissett, D.
collection PubMed
description Seventy-four patients previously treated in our department for germ cell tumour of the testis underwent a series of tests to determine the frequency of long-term therapeutic complications. All had received cisplatin-based chemotherapy as part of their treatment. There was a significant deterioration in renal function throughout the group. Eighteen (24%) had supine blood pressure greater than systolic 140 mmHg or diastolic 90 mmHg after treatment but hypertension did not correlate with renal impairment. Raynaud's phenomenon was common after chemotherapy (26/74) as was persistent sensory neuropathy (23/74). Although 34% had testosterone levels below the normal range, only six patients had a low free testosterone index with one testis still in situ; 18 patients have fathered children after chemotherapy. Approximately half of the patients completed a psychosexual questionnaire and some 30% of them admitted to sexual problems which they attributed to their treatment. Long-term sequelae of cisplatin-based chemotherapy for testicular malignancy are frequent and persistent, and follow-up of these patients should include prospective measurement of changes in blood pressure.
format Text
id pubmed-1971502
institution National Center for Biotechnology Information
language English
publishDate 1990
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19715022009-09-10 Long-term sequelae of treatment for testicular germ cell tumours. Bissett, D. Kunkeler, L. Zwanenburg, L. Paul, J. Gray, C. Swan, I. R. Kerr, D. J. Kaye, S. B. Br J Cancer Research Article Seventy-four patients previously treated in our department for germ cell tumour of the testis underwent a series of tests to determine the frequency of long-term therapeutic complications. All had received cisplatin-based chemotherapy as part of their treatment. There was a significant deterioration in renal function throughout the group. Eighteen (24%) had supine blood pressure greater than systolic 140 mmHg or diastolic 90 mmHg after treatment but hypertension did not correlate with renal impairment. Raynaud's phenomenon was common after chemotherapy (26/74) as was persistent sensory neuropathy (23/74). Although 34% had testosterone levels below the normal range, only six patients had a low free testosterone index with one testis still in situ; 18 patients have fathered children after chemotherapy. Approximately half of the patients completed a psychosexual questionnaire and some 30% of them admitted to sexual problems which they attributed to their treatment. Long-term sequelae of cisplatin-based chemotherapy for testicular malignancy are frequent and persistent, and follow-up of these patients should include prospective measurement of changes in blood pressure. Nature Publishing Group 1990-10 /pmc/articles/PMC1971502/ /pubmed/2171622 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Bissett, D.
Kunkeler, L.
Zwanenburg, L.
Paul, J.
Gray, C.
Swan, I. R.
Kerr, D. J.
Kaye, S. B.
Long-term sequelae of treatment for testicular germ cell tumours.
title Long-term sequelae of treatment for testicular germ cell tumours.
title_full Long-term sequelae of treatment for testicular germ cell tumours.
title_fullStr Long-term sequelae of treatment for testicular germ cell tumours.
title_full_unstemmed Long-term sequelae of treatment for testicular germ cell tumours.
title_short Long-term sequelae of treatment for testicular germ cell tumours.
title_sort long-term sequelae of treatment for testicular germ cell tumours.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971502/
https://www.ncbi.nlm.nih.gov/pubmed/2171622
work_keys_str_mv AT bissettd longtermsequelaeoftreatmentfortesticulargermcelltumours
AT kunkelerl longtermsequelaeoftreatmentfortesticulargermcelltumours
AT zwanenburgl longtermsequelaeoftreatmentfortesticulargermcelltumours
AT paulj longtermsequelaeoftreatmentfortesticulargermcelltumours
AT grayc longtermsequelaeoftreatmentfortesticulargermcelltumours
AT swanir longtermsequelaeoftreatmentfortesticulargermcelltumours
AT kerrdj longtermsequelaeoftreatmentfortesticulargermcelltumours
AT kayesb longtermsequelaeoftreatmentfortesticulargermcelltumours